Neuropathic pain Market 2017 – Globally Market Size, Analysis, Share, Research, Growth
The report of global neuropathic pain market by Market
Research Future comprises of extensive primary research along with detail
analysis of qualitative as well as quantitative aspects by various industry experts
and key opinion leaders to gain a deeper insight of the market and industry
performance.
Market Scenario:
Global neuropathic
pain market was $ 5.5 billion in 2017 and is expected to reach to $ 8.1
billion by growing at the CAGR of 5.5% during forecasted period of 2017-2023.
Neuropathic pain is a chronic pain that occurs due
to tissue injury and is associated with sensor motor system. The major driving
factor for global neuropathy pain market is increasing prevalence of diseases
like cancer and diabetes. These two diseases are major cause for neuropathy
pain. According to the latest study, 16 % of global population is suffering
from painful diabetic neuropathy. Beside this increase in the demand for
generic drugs and rapid launch of new neuropathic drug in the market has
provided fuel for the growth of this market. On the other hand increasing side
effects of steroids and increasing cost of branded drugs may hamper the growth
of this market.
Get Sample Copy at https://www.marketresearchfuture.com/sample_request/1390
.
Key Players in the global Neuropathic
Pain Market
Some of the key players in this market are Pfizer
Inc., Depomed Inc., Johnson & Johnson Services Inc., Eli Lily and Company,
GlaxoSmithKline PLC, Bristol-Myers Squibb and Company, Sanofi S.A, Baxter
Healthcare Corporation, and Biogen Idec Inc.
Segmentation
The market is segmented into following which
includes by drug types (anticonvulsants, antidepressant, anaesthesia, steroids
and other), by condition (Peripheral neuropathy, diabetic neuropathy and other)
and by end user (retail pharmacies, hospitals and other)
Regional Analysis
On regional basis, North America dominates the
neuropathic pain market. Due to increase in number of diseases like diabetes
and cancer in this region, all these have developed the market in North
America. Beside this increasing aging population in this region has also
provided a push to the market’s growth. In neuropathic pain market North
America is followed by Europe. Improved infrastructure, increase in
technological advance and prevalence of diseases which causes neuropathic pain
has led to the growth of this market in Europe.
Asia Pacific is a developing region. Due to a huge
demand of advance treatment for neuropathic pain along with increase in
prevalence of diabetes in this region all these will allow growth of this
market by the CAGR of 6.4% during the forecasted period.
Brief
TOC:
1
INTRODUCTION
1.1
DEFINITION
1.2 SCOPE
OF STUDY
1.2.1 RESEARCH
OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.2.2.1 ASSUMPTIONS
1.2.2.2 LIMITATIONS
1.3
MARKET STRUCTURE:
2
RESEARCH METHODOLOGY
2.1
RESEARCH
PROCESS:
2.2
PRIMARY RESEARCH
2.3
SECONDARY RESEARCH:
3
MARKET DYNAMICS
3.1
DRIVERS
3.2
RESTRAINTS
3.3
OPPORTUNITIES
3.4
MACROECONOMIC INDICATORS
4
MARKET FACTOR ANALYSIS
…Continued
Get
Discount at https://www.marketresearchfuture.com/check-discount/1390
.
The report gives a clear picture of current market
scenario which includes past and estimated future market size in terms of value
and volume, technological advancement, macro economical and governing factors
in the market. The report provides detail information about and strategies used
by top key players in the industry. The report also gives a broad study of the
market’s segments and regions.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact:
Akash Anand,
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
Comments
Post a Comment